Canada-based MediPharm Labs Corp. MLCPF will supply cannabis oil concentrate to an unnamed licensed producer under the terms of a CA$35-million ($26.38 million) deal.
What Happened
Under the terms of the supply agreement, the licensed producer will purchase CA$7.66 million in canabis oil concentrate this month. Over a 12-month period commencing in March, MediPharm will supply a minimum of CA$27 million worth of oil concentrate.
The buyer also has the option to purchase an additional CA$13.5 million worth of concentrate over the same period.
Why It's Important
The latest deal is the fourth under MediPharm's private label program, under which it buys cannabis flower and trim from supply partners and produces cannabis oil concentrate products that are resold on a private label basis. The four deals signed so far generated have a value of more than CA$85 million in the 15-month period beginning in December, according to MediPharm.
What's Next
The latest deal — in combination with a previously announced long-term supply agreement with Canopy Growth Corp CGC — represents less than 10 percent of MediPharm Labs' annual extraction capacity of 150,000 kg. MediPharm said it's working to expand its annual extraction capacity to 250,000 kilograms and expects to complete the project in the second quarter.
Related Links:
MediPharm Labs Hits 331-Pound Cannabis Extraction Milestone
Canaccord's Takeaways From Aurora's First Full Quarterly Earnings Print
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.